Nasdaq · GILD
Gilead Sciences
Gilead Sciences (GILD) is listed on Nasdaq, in the Health Care sector (Biotechnology). It is in the S&P 500 and the Nasdaq-100. This page shows a TradingView chart for GILD and the company's recent annual and quarterly reports from the SEC EDGAR database. It does not include a price quote.
SEC filings
Industry code, fiscal year and filing dates come from the SEC’s EDGAR submissions feed for CIK 882095. The annual report is a Form 10-K, or a 20-F or 40-F for a foreign issuer. The quarterly report is a Form 10-Q when the company files one.
- SIC
- 2836 · Biological Products, (No Diagnostic Substances)
- Fiscal year ends
- December 31
- Incorporated
- Delaware
- Latest annual report
- 10-K filed February 24, 2026
- Latest quarterly report
- 10-Q filed October 30, 2026
- All filings
- Gilead Sciences on EDGAR
More in Health Care
Questions about tracking GILD
Does this page show a live price?
The number you see in the chart is rendered by TradingView’s widget in your browser. Rovex does not print a quote of its own on this page. A free account adds GILD to a watchlist; email alerts, when that deployment has them, run inside the app.
Where do the filing dates come from?
From the SEC’s EDGAR submissions feed for CIK 882095. The link opens the filing on sec.gov. Rovex is not affiliated with the SEC.
Track GILD free on Rovex
Save it to a watchlist, keep the chart open in a tab, and read the filings from one place. Rovex is not a broker, and nothing here is investment advice.